Ono, Koh

MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 ( Srebp2 ) regulates HDL in vivo

Horie, T., Ono, K., Horiguchi, M., Nishi, H., Nakamura, T., Nagao, K., Kinoshita, M., Kuwabara, Y., Marusawa, H., Iwanaga, Y., et al. (2010) · Proceedings of the National Academy of Sciences

Cholesterol and Lipid MetabolismMicroRNA in disease regulation

Cited by 384

MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice

Horie, T., Nishino, T., Baba, O., Kuwabara, Y., Nakao, T., Nishiga, M., Usami, S., Izuhara, M., Sowa, N., Yahagi, N., et al. (2013) · Nature Communications

MicroRNA in disease regulationCholesterol and Lipid Metabolism

Cited by 230

MicroRNA‐33 Deficiency Reduces the Progression of Atherosclerotic Plaque in ApoE −/− Mice

Horie, T., Baba, O., Kuwabara, Y., Chujo, Y., Watanabe, S., Kinoshita, M., Horiguchi, M., Nakamura, T., Chonabayashi, K., Hishizawa, M., et al. (2012) · Journal of the American Heart Association

Cholesterol and Lipid MetabolismMicroRNA in disease regulation

Cited by 220

MicroRNAs and cardiovascular diseases

Ono, K., Kuwabara, Y., & Han, J. (2011) · The FEBS Journal

MicroRNA in disease regulationCongenital heart defects research

Cited by 169

microRNA-33 Regulates ApoE Lipidation and Amyloid-β Metabolism in the Brain

Kim, J., Yoon, H., Horie, T., Burchett, J. M., Restivo, J. L., Rotllan, N., Ramírez, C. M., Verghese, P. B., Ihara, M., Hoe, H.-S., et al. (2015) · The Journal of Neuroscience

Alzheimer's disease research and treatmentsMicroRNA in disease regulation

Cited by 128

Leptin induces elongation of cardiac myocytes and causes eccentric left ventricular dilatation with compensation

Abe, Y., Ono, K., Kawamura, T., Wada, H., Kita, T., Shimatsu, A., & Hasegawa, K. (2007) · American Journal of Physiology-Heart and Circulatory Physiology

Cardiac Fibrosis and RemodelingCardiovascular Function and Risk Factors

Cited by 97

Genetic Ablation of MicroRNA-33 Attenuates Inflammation and Abdominal Aortic Aneurysm Formation via Several Anti-Inflammatory Pathways

Nakao, T., Horie, T., Baba, O., Nishiga, M., Nishino, T., Izuhara, M., Kuwabara, Y., Nishi, H., Usami, S., Nakazeki, F., et al. (2017) · Arteriosclerosis, Thrombosis, and Vascular Biology

Aortic aneurysm repair treatmentsMicroRNA in disease regulation

Cited by 81

CCN1 Knockdown Suppresses Neointimal Hyperplasia in a Rat Artery Balloon Injury Model

Matsumae, H., Yoshida, Y., Ono, K., Togi, K., Inoue, K., Furukawa, Y., Nakashima, Y., Kojima, Y., Nobuyoshi, M., Kita, T., et al. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology

Connective Tissue Growth Factor ResearchCardiovascular, Neuropeptides, and Oxidative Stress Research

Cited by 59

Intensity of Statin Therapy, Achieved Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Outcomes in Japanese Patients After Coronary Revascularization: – Perspectives From the CREDO-Kyoto Registry Cohort-2 –

Natsuaki, M., Furukawa, Y., Morimoto, T., Nakagawa, Y., Ono, K., Kaburagi, S., Inada, T., Mitsuoka, H., Taniguchi, R., Nakano, A., et al. (2012) · Circulation Journal

Lipoproteins and Cardiovascular HealthCoronary Interventions and Diagnostics

Cited by 49

microRNA-33 maintains adaptive thermogenesis via enhanced sympathetic nerve activity

Horie, T., Nakao, T., Miyasaka, Y., Nishino, T., Matsumura, S., Nakazeki, F., Ide, Y., Kimura, M., Tsuji, S., Rodriguez, R. R., et al. (2021) · Nature Communications

Adipose Tissue and MetabolismMicroRNA in disease regulation

Cited by 49

MicroRNA-33b knock-in mice for an intron of sterol regulatory element-binding factor 1 (Srebf1) exhibit reduced HDL-C in vivo

Horie, T., Nishino, T., Baba, O., Kuwabara, Y., Nakao, T., Nishiga, M., Usami, S., Izuhara, M., Nakazeki, F., Ide, Y., et al. (2014) · Scientific Reports

Cholesterol and Lipid MetabolismMicroRNA in disease regulation

Cited by 49

SREBF1/MicroRNA-33b Axis Exhibits Potent Effect on Unstable Atherosclerotic Plaque Formation In Vivo

Nishino, T., Horie, T., Baba, O., Sowa, N., Hanada, R., Kuwabara, Y., Nakao, T., Nishiga, M., Nishi, H., Nakashima, Y., et al. (2018) · Arteriosclerosis, Thrombosis, and Vascular Biology

Cholesterol and Lipid MetabolismMicroRNA in disease regulation

Cited by 33

MicroRNAs and Lipoprotein Metabolism

Horie, T., Baba, O., Kuwabara, Y., Yokode, M., Kita, T., Kimura, T., & Ono, K. (2014) · Journal of Atherosclerosis and Thrombosis

MicroRNA in disease regulationCholesterol and Lipid Metabolism

Cited by 29

Identification of Differential Roles of MicroRNA‐33a and ‐33b During Atherosclerosis Progression With Genetically Modified Mice

Koyama, S., Horie, T., Nishino, T., Baba, O., Sowa, N., Miyasaka, Y., Kuwabara, Y., Nakao, T., Nishiga, M., Nishi, H., et al. (2019) · Journal of the American Heart Association

Cholesterol and Lipid MetabolismMicroRNA in disease regulation

Cited by 23

Inhibition of microRNA-33b in humanized mice ameliorates nonalcoholic steatohepatitis

Miyagawa, S., Horie, T., Nishino, T., Koyama, S., Watanabe, T., Baba, O., Yamasaki, T., Sowa, N., Otani, C., Matsushita, K., et al. (2023) · Life Science Alliance

Liver Disease Diagnosis and TreatmentMicroRNA in disease regulation

Cited by 14

Inhibition of microRNA-33b specifically ameliorates abdominal aortic aneurysm formation via suppression of inflammatory pathways

Yamasaki, T., Horie, T., Koyama, S., Nakao, T., Baba, O., Kimura, M., Sowa, N., Sakamoto, K., Yamazaki, K., Obika, S., et al. (2022) · Scientific Reports

Aortic aneurysm repair treatmentsMicroRNA in disease regulation

Cited by 13

MicroRNA 33 Regulates the Population of Peripheral Inflammatory Ly6C high Monocytes through Dual Pathways

Baba, O., Horie, T., Nakao, T., Hakuno, D., Nakashima, Y., Nishi, H., Kuwabara, Y., Nishiga, M., Nishino, T., Ide, Y., et al. (2018) · Molecular and Cellular Biology

MicroRNA in disease regulationAtherosclerosis and Cardiovascular Diseases

Cited by 12

MicroRNA-33 inhibition ameliorates muscular dystrophy by enhancing skeletal muscle regeneration

Sowa, N., Horie, T., Ide, Y., Baba, O., Kora, K., Yoshida, T., Nakamura, Y., Matsumura, S., Matsushita, K., Imanaka, M., et al. (2025) · EMBO Molecular Medicine

Muscle Physiology and DisordersCongenital heart defects research

Cited by 4